DK1005492T3 - Oprensning af von Willebrand-faktor ved kationbytterchromatografi - Google Patents

Oprensning af von Willebrand-faktor ved kationbytterchromatografi

Info

Publication number
DK1005492T3
DK1005492T3 DK98901870T DK98901870T DK1005492T3 DK 1005492 T3 DK1005492 T3 DK 1005492T3 DK 98901870 T DK98901870 T DK 98901870T DK 98901870 T DK98901870 T DK 98901870T DK 1005492 T3 DK1005492 T3 DK 1005492T3
Authority
DK
Denmark
Prior art keywords
purification
cation exchange
exchange chromatography
von willebrand
willebrand factor
Prior art date
Application number
DK98901870T
Other languages
English (en)
Inventor
Bernhard Fischer
Oeyvind L Schoenberger
Artur Mitterer
Christian Fiedler
Friedrich Dorner
Johann Eibl
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of DK1005492T3 publication Critical patent/DK1005492T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Confectionery (AREA)
DK98901870T 1997-02-27 1998-02-18 Oprensning af von Willebrand-faktor ved kationbytterchromatografi DK1005492T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0033797A AT405403B (de) 1997-02-27 1997-02-27 Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
PCT/AT1998/000034 WO1998038219A1 (de) 1997-02-27 1998-02-18 Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie

Publications (1)

Publication Number Publication Date
DK1005492T3 true DK1005492T3 (da) 2007-08-13

Family

ID=3487918

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98901870T DK1005492T3 (da) 1997-02-27 1998-02-18 Oprensning af von Willebrand-faktor ved kationbytterchromatografi

Country Status (11)

Country Link
US (1) US6465624B1 (da)
EP (1) EP1005492B1 (da)
JP (1) JP4250770B2 (da)
AT (2) AT405403B (da)
AU (1) AU737986B2 (da)
CA (1) CA2282843C (da)
DE (1) DE59813967D1 (da)
DK (1) DK1005492T3 (da)
ES (1) ES2285754T3 (da)
NO (1) NO324659B1 (da)
WO (1) WO1998038219A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
US6531577B1 (en) * 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
AT408443B (de) * 1998-02-27 2001-11-26 Immuno Ag Verfahren zur gewinnung von gereinigtem faktor viii:c/vwf-komplex
US6605222B1 (en) * 1998-05-20 2003-08-12 Baxter Aktiengesellschaft Method for producing a factor VIII/von Willebrand factor complex
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
JP2008512097A (ja) * 2004-09-07 2008-04-24 アーケミックス コーポレイション アプタマー医薬品化学
US7566701B2 (en) * 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
KR20070101227A (ko) 2004-09-07 2007-10-16 아케믹스 코포레이션 폰 빌레브란트 인자에 대한 앱타머 및 이의 혈전증치료제로서의 용도
DE102004044419B4 (de) 2004-09-14 2010-04-15 Biotest Ag Verfahren zur Aufreinigung eines von Willebrand Faktors mittels Hydroxylapatit-Durchlaufchromatographie
DE102004044429B4 (de) 2004-09-14 2009-04-30 Biotest Ag Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor
CA2591852A1 (en) 2004-12-27 2006-07-06 Baxter International Inc. Polymer-von willebrand factor-conjugates
CA2647314A1 (en) 2006-03-31 2007-11-08 Baxter International Inc. Pegylated factor viii
US20090203766A1 (en) * 2007-06-01 2009-08-13 Archemix Corp. vWF aptamer formulations and methods for use
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
CN105816858B (zh) 2007-12-28 2024-10-18 武田药品工业株式会社 重组vwf配方
EP2349314B1 (en) 2008-10-21 2013-02-27 Baxter International Inc. Lyophilized recombinant vwf formulations
AU2010284116B9 (en) * 2009-08-20 2015-03-26 Takeda Pharmaceutical Company Limited Purification of VWF for increased removal of non-lipid enveloped viruses
CA2821711C (en) 2010-12-15 2017-10-10 Baxter International Inc. Eluate collection using conductivity gradient
ES2682249T3 (es) * 2011-06-10 2018-09-19 Baxalta GmbH Tratamiento de una enfermedad de la coagulación mediante la administración de VWF recombinante
PL3158055T3 (pl) 2014-06-13 2020-03-31 Csl Limited Ulepszone wytwarzanie rekombinowanego czynnika von Willebranda w bioreaktorze
CA3069295A1 (en) 2017-07-07 2019-01-10 Baxalta Incorporated Treatment of gastrointestinal bleeding in patients with severe von willebrand disease by administration of recombinant vwf
CA3094644A1 (en) 2018-03-21 2019-09-26 Baxalta Incorporated Separation of vwf and vwf propeptide by chromatographic methods
US12128090B2 (en) 2019-02-01 2024-10-29 Takeda Pharmaceutical Company Limited Methods of prophylactic treatment using recombinant VWF (rVWF)
JP7780433B2 (ja) 2019-12-10 2025-12-04 ビオテスト・アクチエンゲゼルシャフト フィブリノゲン製剤の製造方法
CN116284337A (zh) * 2023-03-30 2023-06-23 同路生物制药有限公司 以冷沉淀peg沉淀及色谱层析法制备血友病因子的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361509A (en) 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US5006642A (en) 1987-06-29 1991-04-09 Rhone-Poulenc Rorer Pharmaceuticals Inc. Purification of von Willebrand Factor by affinity chromatography
FR2632309B1 (fr) 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
DE3904354A1 (de) 1989-02-14 1990-08-16 Behringwerke Ag Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung
FR2665449B1 (fr) * 1990-08-02 1995-04-14 Aquitaine Developp Transf Sang Procede de fabrication de facteur von willebrand ayant une tres haute purete, depourvu en majeure partie de facteur antihemophilique (fviiic), et facteur von willebrand ainsi obtenu, ainsi qu'une composition pharmaceutique le contenant.
NZ237244A (en) 1990-03-02 1992-10-28 Bio Technology General Corp Cloning and production of human von willebrand factor analogues and compositions thereof
FR2673632A1 (fr) 1991-03-08 1992-09-11 Lille Transfusion Sanguine Procede de preparation de concentre de facteur von willebrand humain de tres haute purete, approprie a un usage therapeutique.
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
IT1256622B (it) * 1992-12-04 1995-12-12 Sclavo Spa Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale.
AT401270B (de) 1994-09-26 1996-07-25 Immuno Ag Verfahren zur quantifizierung von genomischer dna
CA2159044A1 (en) 1994-09-26 1996-03-27 Falko-Guenter Falkner Method of quantitating nucleic acids
DE4435392B4 (de) 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
DE4435485C1 (de) 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
US5887152A (en) 1995-04-12 1999-03-23 Advanced Micro Devices, Inc. Load/store unit with multiple oldest outstanding instruction pointers for completing store and load/store miss instructions

Also Published As

Publication number Publication date
JP4250770B2 (ja) 2009-04-08
US6465624B1 (en) 2002-10-15
WO1998038219A1 (de) 1998-09-03
EP1005492A1 (de) 2000-06-07
DE59813967D1 (de) 2007-05-24
CA2282843C (en) 2008-12-02
NO994138D0 (no) 1999-08-26
AU737986B2 (en) 2001-09-06
EP1005492B1 (de) 2007-04-11
NO994138L (no) 1999-08-26
AT405403B (de) 1999-08-25
ES2285754T3 (es) 2007-11-16
NO324659B1 (no) 2007-11-26
AU5847098A (en) 1998-09-18
ATE359301T1 (de) 2007-05-15
JP2001513088A (ja) 2001-08-28
CA2282843A1 (en) 1998-09-03
ATA33797A (de) 1998-12-15

Similar Documents

Publication Publication Date Title
DK1005492T3 (da) Oprensning af von Willebrand-faktor ved kationbytterchromatografi
ATE73856T1 (de) Reinigung, herstellung und verwendung von tumor- nekrosisfaktoren.
BR1100044A (pt) Composições de eritropoietinas homogêneas
DK1015587T3 (da) DcR3 polypeptid, en TNFR-homolog
ES8600690A1 (es) Procedimiento de purificar factores antihemofilicos y similares
DE69819163D1 (de) Reinigung von difluormethan durch extraktivdestillation
HRP20020480B1 (en) Process for the purification of pharmacologically active proteins through cationic exchange chromatography
LV10053A (lv) Kompleksa "Faktors-YIII + fon Villebranda faktors" koncentrata iegusanas metode
ES2051684T3 (es) Metodo de preparacion de inhibidor alfa-1-proteinasa.
ES2070855T3 (es) Metodo para purificar una proteina.
DE60042343D1 (de) Abtrennung von fibrinogen von plasmaproteasen
DE3578744D1 (de) Natriumarmes, als kochsalzsubstitut geeignetes salzgemisch.
FI943545L (fi) Menetelmä tekijän VIII, jonka puhtausaste on korkea ja josta virukset on inaktivoitu, saamiseksi talteen anioninvaihtokromatografian avulla
ATE222925T1 (de) Verbessertes verfahren zur herstellung von faktor viii
ATE247131T1 (de) Verfahren zur reinigung einer rohen albuminwässerigen lösung
BRPI0417252A (pt) processo de purificação de beta interferon humano
ATE278705T1 (de) Verfahren zur reinigung von proteinen
DK0383645T3 (da) Fremgangsmåde til fremstilling af antihæmofilifaktor (FVIIIc) med meget høj renhed
KR960014343A (ko) 활성형 인 과립구 콜로니 자극인자의 정제방법
DE69101425D1 (de) Methode zur Reinigung von rohem glycidyl (Meth)-Acrylat.
FI891121A7 (fi) Menetelmä tekijä XIII:n puhdistamiseksi affiniteettikromatografialla
NO980376D0 (no) Rengjörende blanding omfattende en alifatisk hydrokarbonforbindelse med minst to aromatiske substituenter
RU97110634A (ru) Способ получения рекомбинантного интерферона- гамма человека
DK0408734T3 (da) Fremgangsmåde til rensning af streptokinaser
KR900013072A (ko) 친화성 크로마토그래피법에 의한 소형 전기가오리의 효소인 아세틸콜린에스테라제의 정제방법